Lilac-Centro DCA has successfully closed a €693,000 funding round to enhance its innovative digital approach to treating eating disorders in Italy.
Target Information
Lilac-Centro DCA is a digital health technology startup based in Bari, Italy, founded in 2023 by Giuseppe Magistrale and Filippo Perotto. The company addresses an urgent need in the treatment of eating disorders, including anorexia, bulimia, and binge eating disorder, by employing a multidisciplinary approach that integrates psychological and nutritional support with advanced technological tools. It aims to provide personalized care, both online and in-person, marking itself as a pioneering entity in Italy's healthcare landscape.
Since its inception, Lilac-Centro DCA has developed a network of over 60 specialized psychologists and dieticians trained in psychotherapy and eating disorder treatment. The startup has managed over 6000 treatment requests and has cultivated a community of more than 160,000 members, showcasing its significant impact in the field and the high demand for its services within Italy.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The landscape of mental health and nutritional support for eating disorders in Italy is critical yet under-resourced, with over 3 million individuals affected. Despite the growing acknowledgment of the
Similar Deals
SPRIM Global Investments → Napo Therapeutics
2023
Red Lions Holding → Medical Microinstruments (MMI)
Personae, Sullivan Venture, Generaimprese, Milano Venture
invested in
Lilac-Centro DCA
in 2025
in a Other VC deal
Disclosed details
Transaction Size: $1M